A cancer test company incorrectly informed around 400 patients that they may have developed cancer, a company said, after there was a software issue with its telemedicine provider.
Grail Inc, an American biotechnology company, developed an early-detection blood test called Galleri, created to identify more than 50 types of cancer before symptoms appear, per Reuters. Ref: BI/wire
